Volume 9, Number 3—March 2003
Dispatch
Persistence of Virus-Reactive Serum Immunoglobulin M Antibody in Confirmed West Nile Virus Encephalitis Cases
Table 1
IgM and IgG P/N values of WNV virus patient serum samples by days after onseta
Case no. | Sample | Days after onset | WNV IgM | WNV IgG |
---|---|---|---|---|
1 |
S1 |
12 |
14.3 |
2.0 |
S2 |
197 |
3.9 |
7.8 |
|
S3 |
340 |
3.5 |
8.2 |
|
S4 |
498 |
2.8 |
nda |
|
2 |
S1 |
97 |
12.0 |
5.3 |
S2 |
378 |
3.2 |
nd |
|
3 |
S1 |
72 |
8.2 |
5.0 |
S2 |
186 |
7.3 |
7.0 |
|
S3 |
388 |
1.0 |
nd |
|
4 |
S1 |
27 |
17.3 |
3.4 |
S2 |
311 |
2.7 |
6.4 |
|
5 |
S1 |
31 |
11.0 |
5.5 |
S2 |
215 |
2.8 |
7.9 |
|
S3 |
374 |
1.3 |
nd |
|
6 |
S1 |
39 |
5.9 |
2.8 |
S2 |
173 |
7.6 |
3.9 |
|
S3 |
332 |
3.5 |
4.3 |
|
S4 |
502 |
3.1 |
nd |
|
7 |
S1 |
29 |
11.5 |
4.8 |
S2 |
189 |
6.7 |
6.3 |
|
S3 |
332 |
2.7 |
6.2 |
|
S4 |
536 |
2.8 |
nd |
|
8 |
S1 |
3 |
3.3 |
6 |
S2 |
15 |
10.7 |
5.0 |
|
S3 |
30 |
nd |
5.3 |
|
S4 |
43 |
4.1 |
5.4 |
|
S5 |
204 |
3.5 |
6.2 |
|
S6 |
343 |
2.2 |
7.0 |
|
S7 |
508 |
1.8 |
nd |
|
9 |
S1 |
21 |
13.6 |
4.4 |
S2 |
199 |
1.7 |
3.2 |
|
10 |
S1 |
55 |
9.0 |
3.7 |
S2 |
189 |
10.8 |
6.0 |
|
11 |
S1 |
17 |
24.6 |
5.2 |
S2 |
255 |
3.6 |
4.3 |
|
S3 |
336 |
3.1 |
7.5 |
|
S4 |
512 |
6.9 |
nd |
|
12 |
S1 |
11 |
13.4 |
5.3 |
S2 |
13 |
15.0 |
5.6 |
|
S3 |
24 |
11.4 |
5.8 |
|
S4 |
533 |
1.8 |
nd |
|
13 |
S1 |
8 |
16.7 |
3.4 |
S2 |
202 |
4.2 |
nd |
|
14 |
S1 |
16 |
7.8 |
2.4 |
S2 |
30 |
3.5 |
5.6 |
|
S3 |
349 |
1.7 |
7.0 |
|
15 |
S1 |
17 |
17.2 |
5.6 |
S2 |
192 |
2.2 |
6.3 |
|
S3 |
335 |
1.4 |
6.8 |
|
16 |
S1 |
7 |
14.0 |
2.0 |
S2 |
29 |
24.5 |
3.7 |
|
S3 |
338 |
6.5 |
6.6 |
|
17 |
S1 |
79 |
8.5 |
5.7 |
S2 |
200 |
7.5 |
4.5 |
|
S3 |
337 |
4.1 |
4.6 |
|
S4 |
525 |
3.6 |
nd |
|
18 |
S1 |
50 |
7.3 |
4.8 |
S2 |
55 |
6.6 |
3.3 |
|
S3 |
68 |
4.4 |
nd |
|
S4 |
207 |
2.9 |
7.3 |
|
S5 |
505 |
1.3 |
nd |
|
19 |
S1 |
4 |
10.5 |
4.0 |
S2 |
14 |
7.3 |
4.1 |
|
S3 |
355 |
1.3 |
nd |
|
20 |
S1 |
29 |
18.0 |
3.1 |
S2 |
257 |
3 |
8.8 |
|
S3 |
373 |
1.7 |
nd |
|
21 |
S1 |
1 |
10.1 |
3.6 |
S2 |
7 |
9.2 |
3.5 |
|
S3 |
180 |
1.2 |
2.8 |
|
22 |
S1 |
6 |
25.7 |
2.4 |
S2 |
185 |
9.1 |
6.9 |
|
S3 |
319 |
3.4 |
8.2 |
|
S4 |
497 |
4.2 |
Nd |
|
23 |
S1 |
25 |
12.3 |
5.5 |
S2 |
204 |
3.0 |
7.2 |
|
S3 |
529 |
1.7 |
nd |
|
24 |
S1 |
4 |
11.4 |
3.2 |
S2 |
8 |
9.1 |
3.5 |
|
S3 |
14 |
19.6 |
2.7 |
|
S4 |
212 |
2.9 |
6.3 |
|
S5 |
361 |
1.9 |
nd |
|
25 |
S1 |
9 |
9.1 |
4.8 |
S2 |
34 |
6.7 |
5.2 |
|
S3 |
223 |
1.5 |
5.0 |
|
26 |
S1 |
10 |
14.8 |
2.3 |
S2 |
22 |
16.1 |
3.7 |
|
S3 |
191 |
10.4 |
3.2 |
|
S4 |
387 |
3.4 |
nd |
|
S5 |
514 |
5.2 |
nd |
|
27 |
S1 |
3 |
11.1 |
3.7 |
S2 |
180 |
7.8 |
5.8 |
|
S3 |
322 |
5.1 |
8.3 |
|
S4 |
518 |
2.4 |
nd |
|
28 |
S1 |
26 |
4.9 |
6.0 |
S2 |
32 |
4.3 |
5.6 |
|
S3 |
298 |
2.2 |
nd |
|
29 | S1 |
217 |
2.4 |
6.7 |
S2 | 351 | 1.8 | 8.1 |
a Ig, immunoglobulin; P/N, positive-to-negative; WNV, West Nile virus nd, not done.